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Key points  22 
1) The clonal diversity of the hematopoietic system declines with age and after 23 
serial transplantation. 24 
 25 
2) Aged HSC acquire mutations that might confer a selective advantage during 26 
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Abstract (limit: 200 words; Current: 200 words) 33 
 34 
Although many recent studies describe the emergence and prevalence of ‘clonal-35 
hematopoiesis of indeterminate-potential’ (CHIP) in aged human populations, a 36 
systematic analysis of the numbers of clones supporting steady-state hematopoiesis 37 
throughout mammalian life is lacking.  Previous efforts relied on transplantation of 38 
‘barcoded’ hematopoietic stem cells (HSC) to track the contribution of HSC clones to 39 
reconstituted blood. However, ex vivo manipulation and transplantation alter HSC 40 
function and thus may not reflect the biology of steady-state hematopoiesis. Using a non-41 
invasive in vivo color-labeling system, we report the first comprehensive analysis of the 42 
changing global clonal complexity of steady-state hematopoiesis during the natural 43 
murine lifespan. We observed that the number of clones (i.e. clonal complexity) 44 
supporting the major blood and bone marrow hematopoietic compartments decline with 45 
age by about 30% and 60%, respectively. Aging dramatically reduced HSC in vivo 46 
repopulating activity and lymphoid potential while increasing functional heterogeneity. 47 
Continuous challenge of the hematopoietic system by serial transplantation provoked the 48 
clonal collapse of both young and aged hematopoietic systems. Whole exome sequencing 49 
of serially transplanted aged and young hematopoietic clones confirmed oligoclonal 50 
hematopoiesis and revealed mutations in at least 27 genes, including nonsense, missense 51 
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Introduction 57 
Advances in technology and medicine have freed modern Homo sapiens from natural 58 
selection imposed by the environment, predation and disease, increasing the incidence of 59 
aging pathologies1. Genomic instability, telomere attrition, epigenetic alterations and 60 
perturbed proteostasis contribute to disrupted tissue homeostasis (i.e. stem cell 61 
exhaustion) in the aged2. Aged blood displays a loss of adaptive immunity and higher 62 
incidences of anemia and myeloid malignancies3. Additionally, expanded hematopoietic 63 
clones are apparent in the peripheral blood (PB) of many aged individuals4-13. >70% of 64 
humans older than 90 years display CHIP (defined as ≥2%PB from a single cellular 65 
clone)4-11. DNMT3A, TET2, ASXL1, PPM1D and JAK2 are often mutated in CHIP 66 
patients6,7, who have a three- and 11-fold greater risk of developing cardiovascular 67 
diseases or leukemia, respectively6,11,14. 68 
 69 
Unknown is how many cellular clones actively contribute to hematopoiesis throughout 70 
life and how these numbers change with age8. Previous studies interrogating clonal 71 
behavior in aged mammalian blood utilized HSC transplantation or mathematical 72 
modeling15,16,17. Transplantation imposes tremendous stress on HSC18. Thus, studies 73 
based entirely on transplantation and ex vivo manipulation of HSC may not accurately 74 
reflect steady-state hematopoiesis19-21. Understanding the dynamics of the clonal 75 
complexity of blood throughout life requires non-invasive strategies.  We recently 76 
reported a new approach to study the endogenous clonal complexity of blood that takes 77 
advantage of a Cre recombinase (CRE) inducible multi-color allele (i.e. Confetti 78 
allele)22,23. Here, employing this approach and multiple CRE labeling strategies, we 79 
 6 
observed a loss of clonal complexity in all hematopoietic compartments with age during 80 
steady-state hematopoiesis. Further, repeated exposure to extreme hematopoietic stress 81 
by serial transplantation resulted in the clonal collapse of both aged and young blood. 82 
Whole exome sequencing (WES) of serially transplanted bone marrow (BM) confirmed 83 
oligoclonal hematopoiesis and identified mutations in aged hematopoietic clones in genes 84 
not previously implicated in HSC self-renewal and maintenance (e.g. Bcl11b, Hist1h2ac, 85 
Npy2r, Notch3, Ptprr, Top2b). These mutations might be important for HSC clonal 86 
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Methods  96 
Mice 97 
C57BL/6J, C57BL/6.SJL-PtprcaPep3b/BoyJ, Flk1+/Cre (Flk1Kdrtm1(cre)Sato/J), 98 
ROSA26+/Confetti (Gt(ROSA)26Sortm1(CAG-Brainbow2.1)Cle/J) and E2a+/Cre (B6.FVB-Tg(EIIa-99 
cre)C5379Lmgd/J) (Jackson Laboratory, Bar Harbor, Maine) mice were housed in a 100 
pathogen-free facility. All animal experiments were carried out according to procedures 101 
approved by the St. Jude Children’s Research Hospital Institutional Animal Care and Use 102 
Committee.  103 
 104 
Genotyping 105 
Genotyping of Cre and Confetti alleles was as previously described23.  106 
 107 
Transplants 108 
0.2x106, 1x106 or 5x106 whole BM cells from young (age two months), old (age 24-26 109 
months) CD45.2+ ROSA26+/ConfettiVE-Cadherin+/Cre mice or from primary, secondary or 110 
tertiary recipient mice were transplanted via tail vein into 8-12 week old 111 
CD45.2+/CD45.1+ C57BL/6J mice previously subjected to 11 Gy of ionizing radiation in 112 
split doses of 5.5 Gy.  113 
 114 
Cell division kinetics 115 
Single HSCs sorted into 96-well plates were inspected to follow division kinetics every 116 
12 hours for 72 hours as described24. Details in Supplemental Materials and Methods. 117 
 118 
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Differentiation potential assay 119 
Single HSCs were sorted into 96-well plates and cultured in myeloid differentiation 120 
medium for 14 days as described25. Emerging colonies were harvested, stained and 121 
analyzed for myeloid lineages. Details in Supplemental Materials and Methods. 122 
 123 
PB Analysis 124 
PB was collected, stained and analyzed as described23.  125 
 126 
Bone Marrow Analysis 127 
BM was harvested from the femurs, tibias, and pelvic bones of mice by crushing. c-Kit+ 128 
cells were enriched using anti-c-Kit microbeads (Miltenyi Biotech, San Diego, CA) 129 
followed by magnetic separation (autoMACS Pro Separator; Miltenyi Biotech). Cells 130 
were stained with antibodies to HSC, MPPs, CMPs, GMPs, MEPs and CLPs. Details in 131 
Supplemental Materials and Methods.   132 
 133 
Statistics and use of formula for predicting cell number from sample-to-sample variance 134 
Summary statistics, including mean, median, minimum, maximum, percentile 25, 135 
percentile 75 and standard deviation were reported. To calculate the clonal complexity of 136 
any tissue at any given time point, we used the mouse-to-mouse variance in Confetti 137 
color distribution23. Detailed in Supplemental Materials and Methods.   138 
 139 
WES-Sample collection, preparation and analysis 140 
 9 
Genomic DNA was isolated using Quick-DNA™ Miniprep Kit (Catalog No. D3024; 141 
Zymo Research, Irvine, CA). Genomic libraries were generated using SureSelectXT kit 142 
specific for the Illumina HiSeq instrument (Catalog No. G9611B; Agilent Technologies, 143 
Santa Clara, CA), followed by exome enrichment (SureSelect XT Mouse All Exon bait 144 
set; Catalog No. 5190-4642).  Exome enriched libraries were then sequenced by the St. 145 
Jude Genome Sequencing Facility. 146 
 147 
To identify somatic mutations within each transplant group, whole-exome-sequences of 148 
CD45.1- Confetti clones isolated from the same donor group were compared to each other 149 
and to CD45.1- Confetti clones isolated from distinct donor groups. Details in 150 
Supplemental Materials and Methods. 151 
 152 
Data sharing statement 153 
For original data please contact shannon.mckinney-freeman@stjude.org. 154 
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Results 156 
The clonal complexity of native hematopoiesis declines with age 157 
To illuminate the clonal dynamics of native hematopoiesis throughout life, we genetically 158 
labeled the hematopoietic system of mouse cohorts during embryonic development and 159 
analyzed the subsequent evolution of global clonal complexity. Specifically, we 160 
examined the mouse-to-mouse variance (MtMV) in Confetti color distribution in the 161 
blood and c-Kit+ BM of cohorts of ROSA26+/ConfettiE2a+/Cre mice (Conf-E2aCre), 162 
ROSA26+/ConfettiFlk-1+/Cre (Conf-Flk-1Cre), ROSA26+/ConfettiVE-Cadherin+/Cre mice (Conf-163 
VECre), and ROSA26+/ConfettiVav1+/Cre mice (Conf-Vav1Cre) from two to 26 months of age 164 
(Figure 1A). The Confetti reporter allele is recombined by CRE and randomly labels 165 
progeny with GFP, YFP, RFP or CFP (Supplemental Figures 1A-B). Here, Confetti 166 
labeling is initiated in blastomeres (Conf-E2aCre), mesodermal hematopoietic precursors 167 
(Conf-Flk-1Cre), hemogenic endothelial precursors (Conf-VECre) and definitive 168 
hematopoietic stem and progenitor cells (HSPCs) (Conf-Vav1Cre) (Figure 1A). As 169 
previously established, large numbers of Confetti+ precursors contributing to a given cell 170 
population results in a small MtMV of Confetti colors while small numbers of Confetti+ 171 
precursors results in high MtMV of Confetti colors (Figure 1B)23. The following formula 172 
estimates the number of contributing clones using the observed MtMV in Confetti colors:  173 
Cell number = 10(−1.56 x log10(CV)+1.47)(where CV= standard deviation/mean and represents 174 
the coefficient of variance). This formula yields accurate estimates of numbers of 175 
contributing clones when that number falls between 50 and 2500 clones23. For Conf-Flk-176 
1Cre, Conf-VECre and Conf-Vav1Cre mice, PB clonal complexity at two months fell within 177 
this range (about 600, Figure 1Ci). As expected, PB and BM clonal complexity of Conf-178 
 11 
E2aCre mice fell below this range, as these mice express CRE when embryos are 179 
comprised of very few cells. It therefore serves as a control for low complexity (Figure 180 
1A-Ci). Thus, about 600 cells labeled during embryonic development represent the 181 
precursors for the entire HSC pool in young adult mice (about 20,000 HSC)26-30. This 182 
number serves as an initial benchmark from which we grossly examined how relative 183 
clonal complexity of blood changes with time. Across CRE lines, PB clonal complexity 184 
was stable until 16-20 months of age, after which it steadily declined for all cohorts 185 
except Conf-E2aCre (Figure 1Ci-Cii, Supplemental Figure 1D). Clonal complexity 186 
dropped slightly earlier in myeloid cells (Supplemental Figure 1D). On average, we 187 
observed a 24% drop in PB clonal complexity of aged mice at 24 and 26 months relative 188 
to young mice (p-value=0.03 and 0.01; FDR q-value(q)=0.1 and 0.06, respectively) 189 
(Figure 1Cii). At 24 months, PB clonal complexity was reduced an average of 11.1%, 190 
37.2% and 44.0% in B cell, T cell and myeloid cell lineages, respectively (Supplemental 191 
Figure 1D). 192 
 193 
Most BM HSPC compartments displayed a drop in overall clonal complexity with age in 194 
Conf-Flk-1Cre, Conf-VECre and Conf-Vav1Cre mice strains (Figure 1Di). On average, the 195 
clonal complexity of HSC and MPP in aged mice decreased by 59.3% (p=0.045, 196 
q=0.1578) and 69.6% (p=0.053, q=0.1578), respectively (Figure 1Dii). While CLP, CMP 197 
and GMP displayed about a 65.6% (p=0.232), 32.3% (p=0.229) and 42.7% (p=0.0964, 198 
q=0.1928) clonal loss, MEP only lost 44.2% (p=0.383) of clonal complexity with age 199 
(Figure 1Dii). As expected, Conf-E2aCre mice showed no loss of BM complexity (Figure 200 
1Di). Altogether, these data reveal a global loss of clonal complexity with age in all BM 201 
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compartments labeled after the blastomere stage. Interestingly, HSC and MPP were more 202 
sensitive to the selective pressures imposed by aging than other HSPC.  203 
 204 
Native hematopoiesis is characterized by clonal instability  205 
Our study and others suggest that native hematopoiesis is polyclonal19,20. The behavior of 206 
individual HSC clones over time can be explained by clonal succession (distinct clones 207 
progressively recruited)31-33, clonal stability (same clones steadily contributing)15,34, 208 
dynamic repetition (a specific clone recruited multiple times)35 or a combination of these 209 
models36. Although our system cannot track individual clones, it can follow “pooled-210 
clones”, which are clones labeled with the same Confetti color. GFP-labeled pools are 211 
particularly useful because Confetti-allele driven GFP labeling is under-favored in most 212 
tissues22,23,37. Thus, GFP+ hematopoietic cells almost certainly reflect the activity of a 213 
smaller pool of clones than RFP, CFP or YFP and are useful for tracking the dynamics of 214 
a relatively small number of clones. 215 
 216 
Here, we analyzed in individual mice the evolution of GFP-labeled clonal pools. Aging 217 
was occasionally accompanied by dramatic changes in PB GFP-labeling (Figure 2, 218 
Supplemental Figure 2). For example, we observed expansions of GFP-pooled-clones 219 
with age (e.g. Conf-E2aCre Mouse #1 and Conf-VE/Cre Mouse #1, Figure 2A). Both 220 
expansion and constriction of GFP-pooled-clones (e.g. Conf-Flk1Cre Mouse #3, Conf-221 
Vav1Cre Mouse #3, Figure 2A) and YFP-pooled-clones were also detected (e.g. Conf-222 
E2aCre Mouse #3, Figure 2A). The relative change in the PB frequency of GFP from 223 
time-point to time-point throughout the life of individual mice revealed this as a common 224 
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phenomenon observed across PB lineages (Figure 2B, Supplemental Figure 2). These 225 
data support a model of PB clonal instability, in which clonal pools wax and wane 226 
throughout life.  227 
 228 
Aging increases the functional heterogeneity of the HSC pool  229 
HSCs give rise to downstream BM progenitors 21. To gain insight into the functional 230 
consequences of aging on HSC, the division kinetics and differentiation potential of 231 
single young and aged HSC was examined. Aged HSCs displayed slower division 232 
kinetics than young HSCs (Figure 3A). Aging also decreased the frequency of multi-233 
potent HSC (Figure 3B, Supplemental Figure 3). These data suggest an increase in HSC 234 
functional heterogeneity with age.  235 
 236 
To address this in vivo, we again examined the behavior of ‘pooled’ clones labeled with 237 
the same Confetti color. A similar distribution of Confetti colors among distinct BM 238 
compartments in individuals reflects a close lineage relationship. For example, when one 239 
examines the BM of Conf-E2aCre Mouse #6 or Conf-VavCre Mouse #5 at 26 months, HSC 240 
and MPP displayed a similar distribution of Confetti colors relative to downstream HSPC 241 
(Figure 3B). To globally analyze these patterns, we calculated the correlation (Pearson’s 242 
correlation coefficient) in the percent contribution of each Confetti color to different cell 243 
lineages in young and old mice (Figure 3C).  The correlation between lineages declined 244 
with age (see color intensity in Figures 3Ci-ii). Remarkably, the correlation between HSC 245 
and MPP was less eroded with age compared to the correlation of HSC with other HSPC 246 
(Figure 3Ciii). Additionally, the pattern of correlation among different lineages in young 247 
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mice was similar in aged mice (see the color pattern in Figures 3Cii and Supplemental 248 
Figure 3B where the scale is modified in young mice to facilitate comparison). These 249 
data suggest that HSC continuously produce MPP throughout life and aging increases the 250 
functional heterogeneity of the HSC pool, which is reflected in the eroded correlations 251 
between HSC and other BM compartments (p-value=0.03). 252 
 253 
Aging constrains HSC repopulating activity 254 
To further investigate the effect of aging on HSC self-renewal and function, we 255 
repeatedly challenged aged HSC by serially transplanting Conf-VECre-BM into irradiated 256 
recipients (Figure 4, Supplemental Figure 4). Here, BM from three independent young 257 
and aged donors was independently serially transplanted into a total of six cohorts of 258 
mice: young BM (groups A-C) and aged BM (groups D-F) (Figures 5-6, Supplemental 259 
Figure 5). Thus, all Confetti+ BM within each group ultimately derives from the same 260 
primary donor.  261 
 262 
Our Confetti-based approach faithfully estimates PB repopulating units (RUs) at short 263 
and long-time points post-transplant23. In primary transplants, many short-term 264 
progenitors contributed to recipient PB regardless of donor age at four weeks post-265 
transplant23,38-40 (Figure 4B). RU numbers decreased over time as these progenitors 266 
exhausted their reconstituting potential for all PB lineages23,38-40 (Figure 4B, 267 
Supplemental Figure 4A-B).  Counterintuitively, PB RUs trended higher in recipients of 268 
aged BM versus recipients of young BM (Figure 4B, Supplemental Figure 4A). 269 
Consistently, reconstituted HSC of aged BM recipients displayed greater clonal 270 
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complexity than recipients of young BM (Figure 4C). Phenotypic HSC are known to 271 
accumulate in aged BM26,27,41-44. Indeed, a 10-fold increase in phenotypic HSC numbers 272 
was apparent in aged Conf-VECre mice relative to young mice (Supplemental Figure 6A). 273 
Thus, the repopulating activity of phenotypic aged HSC appears about half that of young 274 
HSC (ratio of estimated RUs divided by the HSC number), consistent with previous 275 
reports (Supplemental Figure 6B)45,46. Thus, although the phenotypic HSC compartment 276 
expands with age, its activity is compromised relative to young HSC and many more 277 
aged clones are recruited to reconstitute homeostasis. 278 
 279 
Serial transplantation dramatically reduces clonal diversity  280 
Continued serial transplantation of aged and young BM reproducibly resulted in the 281 
dominance of a single Confetti color in reconstituted PB (Figure 5), suggesting 282 
oligoclonality. Accordingly, in secondary transplants of aged and young Conf-VECre-BM, 283 
we observed a loss of clonal diversity in the CD45.2+ PB (including myeloid and 284 
lymphoid lineages) and HSPC (Figure 4B-C, Supplemental Figure 4B).  285 
 286 
As the Confetti formula cannot accurately estimate the clonal complexity of an 287 
oligoclonal system23, we developed an alternate strategy to quantify this progressive loss 288 
of complexity in subsequent transplants, focusing on the frequency of the most prevalent 289 
color as an indicator of clonal diversity expressed as percent of total (Figure 4D, 290 
Supplemental Figure 4C). There was no difference in the rate that young and old serially 291 
transplanted BM achieved clonal dominance in the HSC, MPP and myeloid 292 
compartments (Figure 4D, Supplemental Figure 4C). The differences observed in B- and 293 
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T-cell lineages are probably due to the earlier myeloid bias developed by the aged BM 294 
and that depletes the aged BM from the lymphoid lineages, precluding a proper 295 
comparison (Supplemental Figure 4C, Supplemental Figure 6C). Thus, serial 296 
transplantation steadily and dramatically reduces the clonal diversity of transplanted BM, 297 
regardless of the age of the primary donor. 298 
 299 
Serial transplantation exacerbates clonal instability  300 
To examine the flux of HSC output during serial transplantation, we again analyzed the 301 
behavior of “Confetti-pooled-clones” in individual mice (Figure 5). Dramatic expansions 302 
and constrictions of PB pooled-clones were apparent throughout serial transplantation of 303 
young BM (YFP and RFP in Groups A and B in Figure 5, Figure 6A-B, Supplemental 304 
Figures 5Ai-ii-3Di-ii). Further, in Group A, GFP-pooled-clones steadily increased in 305 
frequency in HSC during serial transplantation (Figure 5, Figure 6D and Supplemental 306 
Figure 5Biv). In contrast, the sudden expansion of GFP-pooled clones in the tertiary and 307 
quaternary PB of Group B recipients was never apparent in recipient HSC and MPP 308 
(Figure 5, Supplemental Figure 5B). For example, the secondary Group B recipient 309 
whose BM was transplanted into tertiary recipients had predominantly CFP+ HSC. 310 
However, the frequency of these CFP-pooled-clones constricted dramatically in tertiary 311 
recipient PB by 16 weeks post-transplant and were a minority fraction in tertiary HSC, 312 
which was overtaken by YFP-pooled clones (Figure 5). In Groups D-F (Figure 5), which 313 
were serially transplanted with aged BM, large expansions of GFP-pooled-clones were 314 
mostly followed by constrictions (Figures 5, 6B, Supplemental Figure 5B). This supports 315 
the presence of small HSC clones with large contribution to PB. For example, the 316 
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distribution of PB pooled clones in Groups D-F secondary recipients were not reflected in 317 
their MPP and HSC (Figure 5, Supplemental Figure 5). In total, these data suggest PB 318 
and HSC clonal instability during serial transplantation. 319 
 320 
Serially transplanted aged BM bears a heavier mutation load than serially 321 
transplanted young BM 322 
Confetti-labeling suggests that serial transplantation of BM results in a loss of clonal 323 
complexity (Figure 4). By quaternary transplants, the majority of reconstituted blood is 324 
only one or two Confetti colors (Figure 5). To confirm clonal hematopoiesis, we 325 
performed WES on CD45.2+ BM labeled with individual Confetti colors (i.e. Confetti-326 
clones) isolated by FACS from quaternary recipients of CD45.2+ Conf-VECre aged or 327 
young BM. 11 Confetti-clones were sequenced: four isolated from recipients of young 328 
BM (Groups A-B) and seven from recipients of aged BM (Groups D-F) (Figure 5, 7, 329 
Table 1, Supplemental Tables 2-3). To ensure identification of true somatic mutations, at 330 
least two Confetti clones labeled with different colors were isolated from each transplant 331 
Group. Since Confetti clones in each Group originate from the same initial donor, 332 
somatic mutations acquired either during aging or serial transplantation can be 333 
distinguished from polymorphisms by comparing independent Confetti clones within a 334 
Group. 335 
 336 
WES revealed 27 mutations (23 missense and 4 nonsense) that change the amino acid 337 
sequences (Table 1, Supplemental Tables 2-3). Five aged Confetti clones (O-1, O-3, O-4, 338 
O-7, O-11) acquired mutations with variant allele frequencies (VAF) close to 50%, 339 
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consistent with monoclonal hematopoiesis (Supplemental Table 3). For example, 340 
virtually all cells in O-4 carried a Cdr1 mutation (VAF=53%), yet this variant was not 341 
observed in O-3 which received cells from the same primary donor. Interestingly, O-4 342 
also harbored a sub-clone, as half of the sample carried a Npy2r mutation (VAF=25.9%) 343 
(Supplemental Table 3). Two aged Confetti clones (O-2, O-6) were oligoclonal (e.g. O-2 344 
was composed of at least two clones (VAFs=10.4% and 14.9%)) (Supplemental Table 3). 345 
Two of four young Confetti clones (Y-2 and Y-3) were clonal (VAF=44% for each) or 346 
oligoclonal (Y-1, subclones were detected with VAFs=16.7% and 13.9%, Supplemental 347 
Table 3).  Interestingly, the average counts of sample-specific mutations per transplant 348 
event (including missense, nonsense, silent and those outside the coding regions) in aged 349 
Confetti clones (4.2 mutations/transplant event) exceeded those of young Confetti clones 350 
(1.4 mutations/transplant event, p=0.02, Figure 7A). These data suggest that most 351 
mutations are acquired during aging or alternatively that aged HSC are more susceptible 352 
to mutagenesis under repeated stress. 353 
 354 
To distinguish between these possibilities, we performed WES on Confetti-labeled young 355 
or aged BM isolated from primary recipients 16 months post-transplant or quaternary 356 
recipients four months post-transplant that were transplanted with cells from the same 357 
primary donor (Figure 7B). Comparing these primary and quaternary samples allowed us 358 
to assess the effect of time and time+repeated serial transplantation. If the observed 359 
mutations accumulated during the aging prior to transplant, then similar mutations should 360 
be observed in both cases. Clones of the same Confetti color within each transplant group 361 
(Two young clones (Y-5 and Y-6) and four aged clones (O-5, O-8, O-9 and O-10) were 362 
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sequenced (Supplemental Table 2). WES showed no overlap in mutations detected in 363 
primary versus quaternary samples (Supplemental Table 2). These data support a model 364 
in which most quaternary mutations are acquired during serial transplantation and aged 365 
BM is more susceptible to mutation during intense hematopoietic stress. Alternatively, 366 
small undetectable clones in primary samples may have been favored by serial 367 
transplantation. 368 
 369 
We assessed if detected mutations were previously identified as variants in hematologic 370 
disease or cancer using Pecan PIE (Pathogenicity Information Exchange) 371 
(https://pecan.stjude.cloud/pie)47. A nonsense mutation in the B-cell CLL/lymphoma 11b 372 
(Bcl11b) locus (c. 610 C>T transition) has been implicated in T-ALL leukemogenesis. 373 
Low BCL11b expression correlates with poor prognosis in T-ALL patients48,49,50. We also 374 
identified a missense damaging mutation (Cys223Tyr) in a conserved, putative Ca+2 375 
binding domain of the Notch3 locus (Cys222 in the human protein) 51-53.  Elevated 376 
NOTCH3 is seen in most T-ALL cases (Table 1 and Supplemental Table 3) 54. A C>T 377 
transition resulted in p379Arg->Trp in protein tyrosine phosphatase receptor type (Ptprr). 378 
Eleven PTPRR R376 mutations have been reported in carcinomas and melanomas47. In 379 
addition, a C>T transition observed in the Neuropeptide Y receptor Y2 (Npy2r) has also 380 
been seen in carcinoma patients (Arg82Cys)55, 47. A G>A transversion in the Histone 381 
cluster 1, H2ac (Hist1h2ac) leading to an Arg33Trp was also observed. Reduced 382 
expression of Hist1h2ac correlates with increased cell proliferation56,57. Finally, we 383 
observed a frameshift deletion in Topoisomerase (DNA) II beta (Top2b), a target for 384 
several anticancer drugs58,59.  385 
 20 
 386 
In sum, WES of young and aged Confetti clones confirmed oligoclonal hematopoiesis 387 
and suggest that aged HSC may be hypersensitive to mutation when subjected to 388 
hematopoietic stress.  389 
  390 
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Discussion 391 
 We comprehensively examined the global clonal complexity of the murine 392 
hematopoietic system throughout life during steady state hematopoiesis. Although the 393 
presence of over-represented clones in aged PB is known, we showed for the first time 394 
that aging correlates with a global loss of clonal diversity in the entire blood system. 395 
These data caution against the use of aged donors for HSC transplantation. We also 396 
visualized the dynamics of clonal instability during native hematopoiesis and extended 397 
previous reports on aged HSC clones15. Our study further illuminated the effect of serial 398 
transplantation on hematopoietic clonal complexity driving a clonal collapse of 399 
reconstituted blood. Finally, we identified mutations that may confer a selective 400 
advantage during hematopoietic stress. 401 
 402 
Here, we utilized a novel, non-invasive approach that depends on the observed MtMV in 403 
Confetti color distribution in cell populations. We previously validated the fidelity of this 404 
approach for estimating clonal numbers and reconstituting events in the blood system 405 
both during ontogeny and transplantation23. The behavior of individual clones are not 406 
tracked in this approach. Rather, much like classic limiting dilution transplantation assays 407 
based on Poisson statistics34,60, MtMV is a statistical, indirect measure of clonal content 408 
and populations. Thus, an important caveat is that if a cell population consistently 409 
contains clones too small to perturb the distribution of Confetti-colors in individual mice, 410 
those clones are essentially ‘hidden’ from MtMV measurements. However, this caveat 411 
can be mitigated by increasing the size of mouse cohorts and numbers of cells analyzed. 412 
Further, with respect to aged HSC, these small ‘hidden’ clones can reflect important 413 
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biology, which is discussed at length below. MtMV is also influenced by cellular 414 
behavior (i.e. changes in the number of clones actively contributing to blood 415 
compartments). Many variables can influence the behavior of cells overtime (e.g. stress, 416 
infection, inflammation, epigenetic remodeling). Behavioral changes with age reflect the 417 
cumulative effect of these many variables on cells (and systems) throughout life. Here, 418 
we applied the MtMV in Confetti color distribution to measure the sum total effect of 419 
these insults on the blood and observed a loss of actively contributing clones in most 420 
blood compartments (Figure 1 and Supplemental Figure 1). Further experimentation will 421 
be necessary to decipher the biology driving changes in active clone numbers in aged 422 
blood.  423 
 424 
Aging is accompanied by a large expansion in phenotypic HSC (Supplemental Figure 425 
6A)26,27,41-44 and a 20-fold decrease in transplantable HSC (Supplemental Figure 6B)8,36-426 
40,53,55-56 61. The precipitous drop in HSC clonal complexity with age suggests that the 427 
expansion of phenotypic HSC results from just a few clones with a selective advantage, 428 
as suggested for CHIP1,8. Further, this loss of HSC complexity does not correlate in 429 
magnitude with the loss of clonal complexity seen in PB (Figure 4B-C, Supplemental 430 
Figure 1D). As aged HSC display poor repopulating activity relative to young HSC 431 
(Supplemental Figure 6B)61, they are likely also compromised in their contribution to 432 
native hematopoiesis. Indeed, the BM frequency of expanded aged HSC Confetti pools is 433 
often not reflected in the blood, suggesting compromised output. We repeatedly observed 434 
aged PB GFP-pooled clones that were undetectable in BM (e.g. Conf-E2aCre #4; Conf-435 
Flk1Cre #6; Conf-VECre #6, Conf-Vav1Cre #6; Figure 3B), consistent with the model that 436 
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small ‘young-like’ HSC clones actively support aged PB, as proposed by de Haan and 437 
Lazare8. Although, in our study, we cannot measure the precise composition of clonal 438 
pools. None-the-less, very likely, only HSC clones that have not expanded dramatically 439 
preserve their functional potential and aged native hematopoiesis is maintained by a 440 
reduced pool of HSC clones8,62. Thus, although PB complexity drops with age, this drop 441 
is not equivalent to that seen in HSC. The pathological significance of harboring large 442 
numbers of phenotypic HSC compromised in differentiative potential is unclear. This 443 
may contribute to the selection of PB clones in elderly CHIP patients. 444 
 445 
Our study complements a recent report estimating that about 50,000-200,000 HSC 446 
contribute to the blood at any given moment in middle-aged individuals63. 16-20 month 447 
old mice are equivalently middle-aged and did not display a loss of PB clonal complexity 448 
(Figure1C). It would be interesting to assess if the 30% drop in complexity seen in our 449 
study is conserved in an elderly (>80 years) individual.  However, this may be difficult to 450 
detect, given the large range of contributing HSC reported in Lee-Six et al63. 451 
 452 
HSC are heterogeneous36,42,64-67. Aging is accompanied by delay in HSC cell division ex 453 
vivo, as previously described68, and a loss of multipotency (Figure 3A), which suggests a 454 
global decline in HSC function. This decline could stem from increasing HSC functional 455 
heterogeneity or from a homogeneous loss of HSC function. Reduced correlation in 456 
Confetti-labeling patterns between BM HSPCs with age supports a model of increased 457 
heterogeneity (Figure 3C). To preserve Confetti color distribution between two BM 458 
compartments: 1) the immature compartment must evenly contribute to the downstream 459 
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compartment, 2) cell expansion and death must be evenly distributed across 460 
compartments and 3) these requirements must hold for any intermediates. Deviation from 461 
these requirements would weaken Confetti color correlations between compartments (i.e. 462 
functional heterogeneity in HSPCs negatively impacts the preservation of Confetti color 463 
distribution between populations). Thus, we favor a model in which aging increases HSC 464 
functional heterogeneity (Figure 3A, Figure 3C).  465 
 466 
Interestingly, HSC and MPP were highly correlated in aged mice (Figure 3Cii-iii). It has 467 
been proposed that MPP support native hematopoiesis with rare contribution from 468 
HSC19,20, which suggests that aged MPP emerge from HSC early in life or that HSC 469 
steadily (but rarely) contribute to MPP. This would also require MPP and HSC to 470 
preserve identical relative rates of symmetric and asymmetric cell division throughout 471 
life (i.e. to preserve Confetti color distributions after a long separation). A simpler model 472 
is that HSC actively and evenly generate MPP throughout life, consistent with the classic 473 
model of hematopoieisis21 474 
 475 
We also examined the effect of age and stress on HSC function. Primary transplantation 476 
of aged BM required recruitment of larger clone numbers than young BM to re-establish 477 
hematopoietic homeostasis (Figure 4B-C, Supplemental Figure 6D), likely because aged 478 
HSC display less repopulating activity/cell than young HSC. Repeated serial 479 
transplantation drove a clonal collapse of the blood in both aged and young mice (Figure 480 
4-6). Our data highlights significant differences between native and stress hematopoiesis 481 
(Figures 1, 4-5, Supplemental Figures 1D and 4). Stress (i.e. transplantation) dramatically 482 
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impacts the diversity of clones contributing to hematopoiesis (Figure 4-5, Supplemental 483 
Figures 4). Although clonal complexity also falls during native hematopoiesis (Figure 1, 484 
Supplemental Fig. 1D), this loss is more gradual and smaller in magnitude than that seen 485 
post-transplant. Thus, to fully appreciate hematopoietic clonal dynamics, it is critical to 486 
interrogate both native and stress hematopoiesis.  487 
 488 
We identified mutations in six genes (i.e. Bcl11b, Hist1h2ac, Npy2r, Notch3, Ptprr and 489 
Top2b) that may confer a selective advantage to HSCs during aging and/or serial 490 
transplantation (Table 1 and Supplemental Table 3). Bcl11b regulates thymocyte 491 
development48,49. Structural variants and mutations in BCL11B have been seen in AML, 492 
pediatric and adult T-ALL and T/myeloid acute bi-lineage leukemia51,69-77,78,79. PTPRR is 493 
a protein tyrosine phosphatase linked to colorectal and cervical cancer80,81,82. NOTCH3 494 
mutations have been causally linked to cerebral autosomal dominant arteriopathy83. High 495 
levels of NOTCH3 are detected regularly in T-ALL54, 84. Variations in the levels of 496 
HIST1H2AC might contribute to carcinogenesis56,57. TOP2B is a DNA topoisomerase 497 
that alleviates topological stress during DNA replication and transcription85. TOP2B 498 
mutations correlate with drug resistance and chromosome translocations in therapy-499 
induced leukemia58,59,86-89. Finally, Npy2r (a G-protein coupled receptor) regulates 500 
memory90,91. We did not detect the most frequent mutations in CHIP patients (e.g. 501 
Dnmt3a, Asxl1, Tet2; total frequency|30%). This could simply be due to the small 502 
number of clones interrogated in our study6,7.  503 
 504 
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In summary, our non-invasive approach constitutes, to our knowledge, the first study of 505 
the dynamics of the absolute clonal complexity of steady state hematopoiesis during a 506 
natural mammalian lifespan. Here, aging resulted in a global loss of clonal complexity 507 
and intense repeated hematopoietic stress compromised HSC self-renewal, regardless of 508 
age, ending in clonal collapse and loss of lymphoid potential. Moreover, we identified 509 
novel mutations that potentially select for HSC capable of extensive self-renewal in the 510 
face of hematopoietic stress. Understanding the functional significance of these mutations 511 
could shed light on similar processes in human clonal hematopoiesis and warrants further 512 
investigation.   513 
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Table 1. Mutations identified that altered amino acid sequences
Gene ID, nucleotide change, amino acid change, age group, type of mutation, conservation in human 
sequence and predicted functional consequences in the protein function are indicated. Mutated genes 
with predicted damaging consequences are highlighted in red. 1 Homologous region was identified in 
Human protein. 2 Predicted based on Polyphen-2 tool.









Csmd1 C T NM_053171:c.5755G>A,p.Ala1919Thr Young missense No N/A
Lmln C T NM_172823:c.1597C>T,p.Gln533* Young nonsense Yes Damaging
Mrgpra6 G A NM_001308537:c.799C>T,p.Arg267Trp Young missense No N/A
Sidt2 G C NM_172257:c.[1062C>G],p.[Tyr354*] Young nonsense Yes Stop gain
Slc5a9 C T NM_145551:c.298G>A,p.Gly100Ser Young missense Yes Damaging
Ahnak C T NM_009643:c.[3092C>T],p.Pro1031Leu Old missense Yes Damaging
Bcl11b G A NM_021399:c.610C>T,p.Gln204* Old nonsense Yes Damaging
Carm1 A G NM_021531:c.[1441A>G],p.[Thr481Ala] Old missense Yes Benign
Cdr1 G A NM_001166658:c.892C>T,p.Arg298Trp Old missense No N/A
Hist1h2ac G A NM_178189:c.97C>T,p.Arg33Trp Old missense Yes Damaging
Grin3a A - NM_001033351:c.[1797delT],p.[Ile599fs] Old deletion Yes Frameshift
Itpkb A G NM_001081175:c.2521A>G,p.Lys841Glu Old missense Yes Benign
Notch3 C T NM_008716:c.668G>A,p.Cys223Tyr Old missense Yes Damaging
Npy2r G A NM_008731:c.244C>T,p.Arg82Cys Old missense Yes Damaging
Olfr1111 G T NM_146593:c.20C>A,p.Thr7Asn Old missense Yes
Probably 
Damaging
Pde6a G A NM_146086:c.161G>A,p.Ser54Asn Old missense Yes Benign
Prb1 G T NM_053251:c.702C>A,p.Asp234Glu Old missense No N/A
Ptprr C T NM_011217:c.1135C>T,p.Arg379Trp Old missense Yes Damaging
Rapgef1 G A NM_001039086:c.2164G>A,p.Glu722Lys Old missense No N/A
Rnf6 C T NM_028774:c.1003G>A,p.Val335Ile Old missense No N/A
Scn2a A C NM_001099298:c.5480A>C,p.Asp1827Ala Old missense Yes Benign
Tada1 T G NM_030245:c.803T>G,p.Leu268Arg Old missense Yes Benign
Tjp1 A G NM_009386:c.4991T>C,p.Ile1664Thr Old missense Yes Benign
Top2b G - NM_009409:c.1487delG,p.Gly497fs Old deletion Yes Frameshift
Vmn2r49 G A NM_001105156:c.647C>T,p.Pro216Leu Old missense No N/A
Zcwpw1 G A NM_001005426:c.34G>A,p.Glu12Lys Old missense No N/A
Zfp735 G T NM_001126489:c.510G>T,p.Lys170Asn Old missense No N/A
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Figure Legends 562 
Figure 1. The global clonal complexity of the hematopoietic system declines with 563 
age. 564 
 a, Schematic of experimental approach. The clonal complexity of the PB and BM of 565 
cohorts of Conf-E2aCre; Conf-VECre; Conf-Flk1Cre and Conf-Vav1Cre mice were examined 566 
at two, seven, 12, 16, 20, 24 and 26 months of age. See Supplemental Figure 1a-b for 567 
schematic of Confetti allele and Confetti color flow cytometry gating strategy. b, i and ii, 568 
Schematic of the inverse relationship between numbers of initially labeled events and 569 
Mouse-to-Mouse Variance (MtMV) in the distribution of Confetti colors. c, i, Analysis of 570 
the clonal complexity of the PB in cohorts of mice from two to 26 months of age. At two 571 
months old: Conf-E2aCre (n=14), Conf-VECre(n=13), Conf-Flk1Cre(n=7), Conf-Vav1Cre 572 
(n=11). At 26 months old, Conf-E2aCre (n=10), Conf-VECre(n=5), Conf-Flk1Cre(n=6), 573 
Conf-Vav1Cre (n=9). ii, Average PB clonal complexity of Conf-Flk1Cre, Conf-VECre and 574 
Conf-Vav1Cre mice overtime relative to two months of age. Error bars indicated standard 575 
deviation. d, i, The clonal complexity of the major BM HSPC from cohorts of mice were 576 
calculated at two and 26 months of age from previously cKit+ enriched BM. At two 577 
months, Conf-E2aCre (n=3), Conf-VECre(n= 6), Conf-Flk1Cre(n=7), Conf-Vav1Cre (n= 8). 578 
At 26 months, Conf-E2aCre (n=7), Conf-VECre(n=4), Conf-Flk1Cre (n= 5), Conf-Vav1Cre 579 
(n=5). ii, Average BM HSPC clonal complexities of Conf-Flk1Cre, Conf-VECre and Conf-580 
Vav1Cre mice overtime relative to two months of age. Error bars indicate standard 581 
deviation. (* p-value0.05; # p-value0.1). Source data are provided in Supplemental 582 
Table 1. iii, Schematic of the consequences of aging on HSC and PB clonal complexity. 583 
The absolute number of phenotypic HSC increase with age (Supplemental Fig. 6A) due 584 
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to the expansion of functionally impaired clones. In aged mice, “young-like” minimally-585 
expanded HSC contribute disproportionately to PB, resulting in a less dramatic decrease 586 
in PB clonal complexity. 587 
 588 
Figure 2. Analysis of pooled clones over time reveals instability in the clonal 589 
composition of PB during native hematopoiesis. 590 
a, Visualization of the distribution of GFP, YFP, RFP and CFP in the PB of 591 
representative Conf-E2aCre, Conf-VECre, Conf-Flk1Cre, Conf-Vav1Cre mice at two, seven, 592 
12, 16, 20, 24 and 26 months of age. b, Fold change in the %GFP relative to the 593 
preceding time-point. Each line represents an independent mouse. Mice from all four 594 
cohorts are shown. Conf-E2aCre (n=9), Conf-VECre (n=7), Conf-Flk1Cre (n=6), Conf-595 
Vav1Cre (n=10). Evolution of %GFP for individual PB lineages is shown in Supplemental 596 
Figure 2 for each mouse, each mouse strain and without normalization. Source data are 597 
provided in Supplemental Table 1. 598 
 599 
Figure 3. Aging functionally compromises HSC and erodes the lineage relationships 600 
between bone marrow compartments during native hematopoiesis. 601 
a, Single HSC from three independent young or aged mice were individually plated in 602 
96-well plates in media that supports HSC expansion (i, n=44-67 clones analyzed/mouse)  603 
or differentiation media (ii, n=27-41 clones were analyzed/mouse). i, Division kinetics 604 
for each well were tracked, % of cumulative number of divisions are shown. ii, % of 605 
clones that generate one, two, three or four myeloid lineages (See Supplemental Figure 606 
3A). Averages are shown, error bars represent standard deviation (# p-value  0.1). b, 607 
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Distribution of Confetti colors in PB and BM in young (age two months) and old (age 26 608 
months) mice. Three representative examples are shown for each mouse strain at each 609 
time-point. c, Heatmaps summarize the correlation of Confetti color distribution between 610 
different hematopoietic compartments in young (i, age two months) and old (ii, age 26 611 
months) mice. Heatmaps depict the Pearson’s correlation coefficient between two cell 612 
compartments. At two months old: Conf-E2aCre (n=14), Conf-VECre(n=13), Conf-Flk1Cre 613 
(n=7), Conf-Vav1Cre (n=11). At 26 months old, Conf-E2aCre (n=10), Conf-VECre(n=5), 614 
Conf-Flk1Cre(n=6), Conf-Vav1Cre (n=9). iii, Correlation values of BM compartments 615 
relative to HSC at 2 and 26 months of age. Paired t test of correlation coefficient of cells 616 
vs. HSC indicate that the correlations are significantly reduced with age (p-value = 0.03). 617 
See also Supplemental Figure 3B. Source data are provided in Supplemental Table 1. 618 
 619 
Figure 4. Serial transplantation of aged and young bone marrow results in a loss of 620 
clonal complexity 621 
a-d, CD45.2+ Conf-VECre BM was serially transplanted. a, Schematic of serial 622 
transplantation of CD45.2+ Conf-VECre BM. For primary transplant, 5x106 BM cells were 623 
transplanted from young (age two months) or old (age 24 months) donors into distinct 624 
cohorts of primary CD45.2+/CD45.1+ recipients. For serial transplants, 5x106 BM cells 625 
were transplanted. For each age group (young and old) at least three independent donor 626 
mice were transplanted into distinct recipient cohorts. Each cohort was composed of at 627 
least five mice and was transplanted with an independent donor. b, Recipient PB was 628 
analyzed for the distribution of Confetti colors in their PB at four, 10 and 16 weeks post-629 
transplant. MtMV was used to estimate the number of repopulating units (see Methods). 630 
 33 
Primary and secondary transplants are shown. (See Supplemental Figure 4 for additional 631 
cell doses transplanted in primary transplants and PB lineages. See also Figure 5). c, 632 
Recipient BM HSC were examined at four months post-transplant for the MtMV in the 633 
Confetti colors. (See Supplemental Figure 6D for additional BM HSPC compartments). 634 
b-c, Averages are shown, error bars denote standard deviation (*p-value0.05; #p-635 
value0.1) d, The median frequency of the most prevalent color is shown for the PB 636 
(four and 16 weeks) and MPP and HSC (16 weeks) for each transplantation stage. 637 
Whisker plots show interquartile range. ANOVA analysis was run to test for the 638 
statistical significance of the transplantation stage and age for each cell type. Age did not 639 
result in statistical differences for any cell type. Transplantation stage had a significant 640 
effect in all cell types (p-values0.05) except HSC. (* p-value0.05). b-d, each bar or 641 
point represents the average or median obtained from at least three independent cohorts 642 
of mice (each cohort nt5) from three independent initial young or old donors. Source 643 
data are provided in Supplemental Table 1. 644 
 645 
Figure 5. Serial transplantation of aged and young bone marrow drives clonal 646 
collapse of reconstituted hematopoiesis 647 
a-b, Pie graphs show the distribution of Confetti colors in the nucleated cells of the PB, 648 
MPP and HSC of each recipient. Each pie graph represents an independent mouse. Each 649 
column of pie charts refers to the same mouse. Vertical arrows indicate donor mice for 650 
the subsequent transplant. Results are shown at four and 16 weeks post-transplant. a, 651 
Serial transplantation from young primary BM donors. b, Serial transplantation from old 652 
primary BM donors. Data related to Figure 4a-c. Source data are provided in 653 
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Supplemental Table 1. Data for HSC and MPP at the quaternary stage is not shown as 654 
they were used for WES. 655 
 656 
Figure 6. Labeled pooled-clones revealed clonal instability during serial 657 
transplantation 658 
The average frequency of CFP-, YFP-, RFP- or GFP-labeled pooled-clones in the PB at 659 
four (a) and 16 weeks (b) and in MPP at 16 weeks (c) and HSC (d) at 16 weeks 660 
throughout transplantation. Results are shown for each transplanted group (#A-F).  661 
Related to Figure 5. Whisker plots show the interquartile range. nt5 for each transplanted 662 
mouse cohort. See Supplemental Figure 5 for the distribution of all pooled-clones. Source 663 
data are provided in Supplemental Table 1.  664 
 665 
Figure 7. Aged Confetti clones exhibit higher mutational rates than young Confetti 666 
clones 667 
Transplanted Conf-VECre BM from aged or young donors was either maintained for 16 668 
months in primary recipients or serially transplanted every four months for a total of 16 669 
months. Confetti sorted clones were subjected to whole-exome-sequencing. a, 670 
Experimental schematic. b, Whole exome sequencing of aged (n=7) and young (n=4) 671 
sorted Confetti clones after serial transplantation. Mutation analysis revealed that aged 672 
clones accumulated a significantly higher number of mutations than young clones when 673 
serially transplanted (* p-value  0.05)  c, Whole exome sequencing of aged (n=4) and 674 
young (n=2) sorted Confetti clones 16 months post-primary transplant. No overlap was 675 
observed in mutations detected after primary transplant compared to repeated 676 
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transplantation (Please see Supplemental Tables 2-3). (b). See also Table 1 and Methods 677 
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